Disease · MONDO_0005665

Bell's palsy

6 sourcesdiseases-2026-09-18-0.1.0

Cite this record

ConductScience Library. Bell's palsy. Diseases, record MONDO_0005665. Release diseases-2026-09-18-0.1.0, 18 Sept 2026. https://conductscience.org/library/diseases/MONDO_0005665

On this page

Disease

Names and IDs as Open Targets gives them. Its IDs in MeSH, Orphanet, the Disease Ontology and the NCI Thesaurus are those Open Targets states for it.

Name: Bell's palsy; Open Targets
Open Targets ID: MONDO_0005665; Open Targets
Other names: Bell Palsy, Bell's (facial) palsy, Cranial nerve VII palsy, Facial palsy, Facial palsy, unilateral or bilateral, Seventh cranial nerve palsy, VII th cranial nerve palsy, facial nerve palsy, facial nerve paralysis, nerve paralysis, Facial, palsy of facial nerve, paralysis Of Facial nerve; Open Targets
Disease Ontology: DOID:12506; Disease Ontology
MeSH: D020330; MeSH
NCI Thesaurus: C26769; NCI Thesaurus
Orphanet: ORPHA:2810; Orphanet
Highest stage of its drugs: Phase 3, for 2 of its 17 drugs, from ClinicalTrials.gov; Open Targets

Drugs17

The drugs Open Targets' clinical reports study for the disease, the highest stage first, then the most trial reports. The stage is Open Targets', the highest any of its sources reports for the pair, and each row names the sources that report it.

Drug	ChEMBL ID	Type	Open Targets' stage	Stage reported by	Reports	Of them trials	Trials shown here	Source
PREDNISONE	CHEMBL635	Small molecule	Phase 3	ClinicalTrials.gov	6	6	3	Drugs and targets
METHYLPREDNISOLONE SODIUM SUCCINATE	CHEMBL1201081	Small molecule	Phase 3	ClinicalTrials.gov	1	1	1	Drugs and targets
PREDNISOLONE	CHEMBL131	Small molecule	Phase 1/2	ClinicalTrials.gov	7	7	5	Drugs and targets
DEXAMETHASONE	CHEMBL384467	Small molecule	Early phase 1	ClinicalTrials.gov	3	3	1	Drugs and targets
TRIAMCINOLONE	CHEMBL1451	Small molecule	Early phase 1	ClinicalTrials.gov	3	3	1	Drugs and targets
TRIAMCINOLONE ACETONIDE	CHEMBL1504	Small molecule	Early phase 1	ClinicalTrials.gov	3	3	1	Drugs and targets
BETAMETHASONE	CHEMBL632	Small molecule	Early phase 1	ClinicalTrials.gov	2	2	0	Drugs and targets
BETAMETHASONE DIPROPIONATE	CHEMBL1200384	Small molecule	Early phase 1	ClinicalTrials.gov	2	2	0	Drugs and targets
BETAMETHASONE SODIUM PHOSPHATE	CHEMBL1200762	Small molecule	Early phase 1	ClinicalTrials.gov	2	2	0	Drugs and targets
METHYLPREDNISOLONE	CHEMBL650	Small molecule	Early phase 1	ClinicalTrials.gov	2	2	0	Drugs and targets

1 to 10 of 17

See all 17 drugs

Targets3

The targets ChEMBL's mechanism records give for the disease's drugs, through Open Targets, the most drugs first. A mechanism record says what a drug acts on, not that the target causes the disease.

Target	Protein	Its drugs that act on it	Mechanisms	Highest stage of those drugs	Gene in Genes	Source
NR3C1	Glucocorticoid receptor	12	Glucocorticoid receptor agonist	Phase 3	https://conductscience.org/library/genes/2908	Drugs and targets
SCN4A	Sodium channel protein type 4 subunit alpha	1	Sodium channel protein type IV alpha subunit blocker	Unknown	https://conductscience.org/library/genes/6329	Drugs and targets
SNAP25	Synaptosomal-associated protein 25	1	Synaptosomal nerve-associated protein 25 (SNAP-25) inhibitor	Unknown	https://conductscience.org/library/genes/6616	Drugs and targets

Trials13

Trials an Open Targets clinical report links to the disease, posted results first, then the largest. A trial is shown when the release's checks confirm its link to the disease and Drugs and targets shows its link to one of the disease's drugs. 2 more are not shown, since the checks do not confirm them.

Trial	Title	Phase	Participants	Results first posted	Conditions	Drugs	Linked by	Source
NCT03508440	Intratympanic Steroid for Bell's Palsy	Phase 2/3	10	2024-11-05	Bell's Palsy, Facial Nerve Paresis	PREDNISONE	Its record names the disease	ClinicalTrials.gov
NCT01201642	Prednisone and Acupuncture for the Treatment of Facial Neuritis: a Multiple Center, CER in China	Not applicable	1,800		Bell's Palsy	PREDNISOLONE	Its record names the disease	ClinicalTrials.gov
NCT01686464	A Clinical Study on the Combined Magnetic and Oxygen Treatment for Bell's Palsy	Not applicable	882		Bell's Palsy	PREDNISONE, VALACYCLOVIR	Its record names the disease	ClinicalTrials.gov
NCT07116811	Steroids for Facial Nerve Function Protection in Post-surgical Vestibular Schwannoma Patients	Phase 3	364		Vestibular Schwannoma, Facial Nerve Paralysis	METHYLPREDNISOLONE SODIUM SUCCINATE	Its record names the disease	ClinicalTrials.gov
NCT06732622	Laser Acupuncture for Idiopathic Bell's Palsy	Not applicable	360		Bell Palsy	PREDNISOLONE	Its record names the disease	ClinicalTrials.gov
NCT06280794	Efficacy of Laser Acupuncture for Idiopathic Bell's Palsy	Not applicable	336		Bell's Palsy	PREDNISOLONE	Its record names the disease	ClinicalTrials.gov
NCT05585346	Photobiomodulation Therapy for Idiopathic Facial Paralysis	Not applicable	96		Bell's Palsy	THIAMINE	Its record names the disease	ClinicalTrials.gov
NCT05821075	Efficacy of Prednisolone Versus Cerebrolysin in the Treatment of Bell's Palsy	Phase 1/2	90		Bell Palsy	PREDNISOLONE	Its record names the disease	ClinicalTrials.gov
NCT05099835	Ultrasound-Guided Stellate Ganglion Block With Botulinum	Not applicable	60		Change From Baseline House-Brackmann	ONABOTULINUMTOXINA, TRIAMCINOLONE ACETONIDE	Its record names the disease	ClinicalTrials.gov
NCT02328079	Steroid-Antiviral Treatment in Rehabilitation of Facial Palsy	Not applicable	50		Facial Palsy	ACYCLOVIR, PREDNISOLONE	Its record names the disease	ClinicalTrials.gov

1 to 10 of 13

See all 13 trials

Comparisons in its trials0

Comparisons Trial comparisons calculated in the trials shown here, most participants first. A comparison in one of these trials does not always compare a treatment for the disease, so read the two groups.

None in this release.

Papers from its trials4

The papers the trials shown here list on ClinicalTrials.gov as their results (RESULT) or as drawn from them (DERIVED), results first, newest first.

PMID	Listed as	Trials listing it	Source
18368417	RESULT	1	PubMed
7829945	RESULT	1	PubMed
27689547	DERIVED	1	PubMed
21693007	DERIVED	1	PubMed

Data dates

The date of each source this release read.

Open Targets: 2026-09-18; Open Targets
Drug links and their checks, from Drugs and targets: 2026-09-18; Drugs and targets
ClinicalTrials.gov, from Trials: 2026-11-12; Trials
Comparisons, from Trial comparisons: 2026-03-23; Trial comparisons
PubMed, for the checks: 2026-11-06; PubMed
MeSH, for the checks: 2026-11-10; MeSH

Sources 6

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ChEMBL, through Open TargetsCC BY-SA 3.0
ClinicalTrials.govNo license stated
NLM's MeSHNLM's terms
Open TargetsCC0 1.0
PubMedNLM's terms

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
ClinicalTrials.govnone stated
NLM's MeSHNLM's
Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
PubMedNLM's terms

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this disease from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/diseases/v1/MONDO_0005665

GET https://conductscience.org/api/diseases/v1/MONDO_0005665/drugs

API reference For AI assistants